New York - London - Athens - Oslo

Closed-End Fund Commentaries


Biotechnology Stocks Still At Reasonable Valuation Levels

Sep 28, 2017
Click here to access Biotechnology Stocks Still At Reasonable Valuation Levels

View from the Observation Deck

1. From 3/9/09 through 9/27/17 (current bull market),the S&P 500 Biotechnology Index posted a cumulative total return of 437.45%, compared to 337.92% for the S&P 500 Health Care Index and 344.09% for the S&P 500 Index, according to Bloomberg.
2. The all-time high for the S&P 500 Biotechnology Index was established on 7/20/15 at a reading of 4,371.83.The index’s P/E ratio stood at 22.80 at the end of July 2015.The index began to sell-off after it peaked on 7/20/15.




provided by:

First Trust

Website: /www.ftportfolios.com